Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Affective Instability in Borderline Personality Disorder
NCT00634062Phase 4Completed
- Sponsor
- McLean Hospital
- Start
- Dec 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in borderline personality disorder (BPD), sponsored by McLean Hospital. Started Dec 2004; status: completed.
02
Drugs
lamotrigine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00634062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634062.